News - InterMune, Cardio-vascular

Filter

Current filters:

InterMuneCardio-vascular

Popular Filters

Longer-term safety profile of InterMune’s Esbriet in IPF demonstrated; Call for greater awareness of PF

26-09-2011

US biotech firm InterMune (Nasdaq: ITMN) has reported that new data at the European Respiratory Society…

BiotechnologyCardio-vascularEsbrietHealthcareInterMunePharmaceuticalResearchRespiratory and Pulmonary

Back to top